SOA Wealth Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
BHIA
NONA
SIM
OIAM
FFM
SOA Wealth Advisors's EW Position: Q2 2026 in Review
SOA Wealth Advisors reduced its Edwards Lifesciences (EW) stake by 1.7% in Q2 2026, selling an estimated $1.26K and leaving 870 shares worth $78.7K. The position accounts for 0.01% of the portfolio, ranked #315.
SOA Wealth Advisors first reported a position in EW in Q4 2020 and has held it in 23 quarters since. The position peaked at $119K in Q4 2021. 265 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- SOA Wealth Advisors held 870 shares of Edwards Lifesciences worth $78.7K as of Q2 2026.
- SOA Wealth Advisors sold 15 Edwards Lifesciences shares in Q2 2026, an estimated $1.26K.
- Edwards Lifesciences made up 0.01% of SOA Wealth Advisors's portfolio in Q2 2026, its #315 holding.
- SOA Wealth Advisors first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 23 quarters since.
- SOA Wealth Advisors's Edwards Lifesciences position peaked at $119K in Q4 2021.
- 265 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.